8 Oral: ALTA3263: an oral, KRAS isoform-selective, dual ON/OFF state, noncovalent inhibitor induces regressions across KRAS G12V, G12D, and G12C cancer models
Titel:
8 Oral: ALTA3263: an oral, KRAS isoform-selective, dual ON/OFF state, noncovalent inhibitor induces regressions across KRAS G12V, G12D, and G12C cancer models
Auteur:
Wang, T. Ibanez, M. Yu, K. Fan, K. Juan, J. Perez, M. Smith, T. Walsh, B. Kang, V. Tyhonas, J. Alvarez, N. Tran, J. Moorefield, K.S. Phimister, A. Zhu, X. Chi, A. Bartberger, M.D. Murphy, E.